Literature DB >> 23495209

Prevalence of diabetes and pre-diabetes in a cohort of Italian young adults with Williams syndrome.

Benedetta Masserini1, Maria Francesca Bedeschi, Vera Bianchi, Giulietta Scuvera, Paolo Beck-Peccoz, Faustina Lalatta, Angelo Selicorni, Emanuela Orsi.   

Abstract

Williams syndrome (WS) is a rare, multisystemic genomic disorder showing a high prevalence of impaired glucose metabolism in adulthood. The reason for this association is unknown, though hemizygosity for genes mapping to the WS chromosome region has been implicated. Twenty-two Italian young adults with WS (13 females, 9 males) were studied. A 75 g oral glucose tolerance test (OGTT) was performed and β-cell function was estimated with Homeostasis Model Assessment (HOMA)-B%, Insulinogenic Index, and corrected insulin response whereas insulin sensitivity was assessed with HOMA-Insulin Resistance Index, Quantitative Insulin Check Index, and composite Insulin Sensitivity Index. One patient had known diabetes mellitus (DM), whereas impaired glucose tolerance (IGT) was diagnosed in 12 patients and DM in one (63.6% prevalence of impaired glucose metabolism). IGT patients were more insulin resistant than those with normal glucose tolerance (NGT), whereas β-cell function was unchanged or increased. Islet autoimmunity was absent. Logistic regression showed that impaired glucose metabolism was not associated with age, body mass index (BMI), or family history of DM. β-cell function, insulin sensitivity, and post-load insulin levels did not differ between WS patients with NGT and healthy controls comparable for gender, age, and BMI, though WS-NGT patients had higher post-load glucose values. These data confirm the high prevalence of impaired glucose metabolism in WS young adults, thus suggesting the need for screening these patients with OGTT. IGT is associated with reduced insulin sensitivity, but not with impaired β-cell function, islet autoimmunity, and traditional risk factors for type 2 DM.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23495209     DOI: 10.1002/ajmg.a.35655

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Glucose and lipid metabolism, bone density, and body composition in individuals with Williams syndrome.

Authors:  Sofia Shaikh; Jessica L Waxler; Hang Lee; Kathy Grinke; Jamie Garry; Barbara R Pober; Takara L Stanley
Journal:  Clin Endocrinol (Oxf)       Date:  2018-09-18       Impact factor: 3.478

2.  Williams-Beuren Syndrome Related Methyltransferase WBSCR27: From Structure to Possible Function.

Authors:  Sofia S Mariasina; Chi-Fon Chang; Tsimafei L Navalayeu; Anastasia A Chugunova; Sergey V Efimov; Viktor G Zgoda; Vasily A Ivlev; Olga A Dontsova; Petr V Sergiev; Vladimir I Polshakov
Journal:  Front Mol Biosci       Date:  2022-06-15

3.  Elastin Insufficiency Predisposes Mice to Impaired Glucose Metabolism.

Authors:  Antea J DeMarsilis; Tezin A Walji; Justine A Maedeker; Kellie V Stoka; Beth A Kozel; Robert P Mecham; Jessica E Wagenseil; Clarissa S Craft
Journal:  J Mol Genet Med       Date:  2014-10

Review 4.  Elastic tissue disruption is a major pathogenic factor to human vascular disease.

Authors:  María M Adeva-Andany; Lucía Adeva-Contreras; Carlos Fernández-Fernández; Manuel González-Lucán; Raquel Funcasta-Calderón
Journal:  Mol Biol Rep       Date:  2021-06-15       Impact factor: 2.316

5.  Impaired glucose metabolism in subjects with the Williams-Beuren syndrome: A five-year follow-up cohort study.

Authors:  Maria Elena Lunati; Maria Francesca Bedeschi; Veronica Resi; Valeria Grancini; Eva Palmieri; Simona Salera; Faustina Lalatta; Giuseppe Pugliese; Emanuela Orsi
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.